XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3Close
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 4,532 $ 5,241 $ 13,442 $ 15,358
Cost of revenue (COR) 1,717 1,624 4,854 4,674
Gross profit 2,815 3,617 8,588 10,684 Close
Research and development (R&D) 471 431 1,403 1,236 Close
Selling, general and administrative (SG&A) 452 431 1,387 1,275 Close
Restructuring charges/other 0 77 0 209 CloseClose
Total Operating Expenses 923.0 939.0 2790.0 2720.0 0 Close
Operating profit 1,892 2,678 5,798 7,964 Close
Other income (expense), net (OI&E) 128 33 327 55 Close
Total Other Income Expenses 226.0 86.0 582.0 209.0 0 Close
Interest and debt expense 98 53 255 154 CloseClose
Income before income taxes 1,922 2,658 5,870 7,865 Close
Provision for income taxes 213 363 731 1,078 Close
Net income $ 1,709 $ 2,295 $ 5,139 $ 6,787 Close
Earnings per common share (EPS):        
Basic (in dollars per share) $ 1.87 $ 2.50 $ 5.63 $ 7.35
Diluted (in dollars per share) $ 1.85 $ 2.47 $ 5.58 $ 7.27
Average shares outstanding:        
Basic (in shares) 908 913 908 919
Diluted (in shares) 916 923 916 929
Diluted EPS:        
Net income $ 1,709 $ 2,295 $ 5,139 $ 6,787
Income allocated to RSUs (10) (11) (26) (30)
Income allocated to common stock for diluted EPS $ 1,699 $ 2,284 $ 5,113 $ 6,757